Maravai LifeSciences Holdings, Inc. Debt Issuance Costs, Gross
Maravai LifeSciences Holdings, Inc. (MRVI) had Debt Issuance Costs, Gross of $1.30 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Debt
us-gaap:DeferredFinanceCostsGross · last filed 2026-05-08
- 2026-03-31: Debt Issuance Costs, Gross $1.30M.
- 2025-09-30: Debt Issuance Costs, Gross $1.50M.
- 2025-06-30: Debt Issuance Costs, Gross $1.60M.
- 2025-03-31: Debt Issuance Costs, Gross $1.70M.
| Period end | Debt Issuance Costs, Gross |
|---|---|
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $1.50M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.60M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-12 |
| 2024-09-30 | $800.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $1.60M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.80M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.00M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $2.40M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $2.60M 10-Q · filed 2022-08-05 |